Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Henry

Showing results (541-550 of 573) with videos related to

Pageof 58
Sort By:
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Adopting Best Practices in the Management of Coronary CalcificationLuiz F Ybarra, Michael J Lim, Suzanne J Baron, et al.
American Heart Journal|November 11, 2019
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shockMarc Samsky, Mitchell Krucoff, Andrew D Althouse, et al.
JACC. Cardiovascular Imaging|May 5, 2022
Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging: A Multisociety ViewpointRon Blankstein, Leslee J Shaw, Martha Gulati, et al.
Journal of the American College of Cardiology|May 21, 2022
Definitions and Standardized Endpoints for Treatment of Coronary BifurcationsMattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 18, 2022
Definitions and Standardized Endpoints for Treatment of Coronary BifurcationsMattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.
Circulation Research|November 9, 2016
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMIArshed A Quyyumi, Alejandro Vasquez, Dean J Kereiakes, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|July 18, 2022
North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital MortalityPayam Dehghani, Christian W Schmidt, Santiago Garcia, et al.
Cell Transplantation|November 22, 2015
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN TrialDoris A Taylor, Emerson C Perin, James T Willerson, et al.
Circulation|June 15, 2007
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trialDouglas W Losordo, Richard A Schatz, Christopher J White, et al.
American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.
Pageof 58

Showing results (541-550 of 573) with videos related to

Sort By:
Pageof 58
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Adopting Best Practices in the Management of Coronary CalcificationLuiz F Ybarra, Michael J Lim, Suzanne J Baron, et al.
American Heart Journal|November 11, 2019
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shockMarc Samsky, Mitchell Krucoff, Andrew D Althouse, et al.
JACC. Cardiovascular Imaging|May 5, 2022
Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging: A Multisociety ViewpointRon Blankstein, Leslee J Shaw, Martha Gulati, et al.
Journal of the American College of Cardiology|May 21, 2022
Definitions and Standardized Endpoints for Treatment of Coronary BifurcationsMattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 18, 2022
Definitions and Standardized Endpoints for Treatment of Coronary BifurcationsMattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.
Circulation Research|November 9, 2016
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMIArshed A Quyyumi, Alejandro Vasquez, Dean J Kereiakes, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|July 18, 2022
North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital MortalityPayam Dehghani, Christian W Schmidt, Santiago Garcia, et al.
Cell Transplantation|November 22, 2015
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN TrialDoris A Taylor, Emerson C Perin, James T Willerson, et al.
Circulation|June 15, 2007
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trialDouglas W Losordo, Richard A Schatz, Christopher J White, et al.
American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.
Pageof 58